FAT TISSUE AND HORMONE DYSFUNCTION
Transcript of FAT TISSUE AND HORMONE DYSFUNCTION
POPULATION DECLINES IN SERUM T(n1=1374, n2=906, n3=489)
The Journal of Clinical Endocrinology & Metabolism, January 2007, 92(1):196–202
POPULATION DECLINES IN SERUM T(n1=1374, n2=906, n3=489)
The Journal of Clinical Endocrinology & Metabolism, January 2007, 92(1):196–202
• LOW-SERUM T• Abdominal obesity• Diabetes
• Pre-diabetes (insulin resistance, impaired glucose tolerance, metabolicsyndrome)
• Dyslipidemia• Low bone and muscle mass• Impaired sexual function• Depressed mood• Decreased quality of life
“Suppose, for instance, there were an unmeasured but persistent environmental exposure associatedwith decreased T levels, affecting recent generations of men at birth.”
ANTIANDROGENS IN EFFLUENTS FROM WASTEWATER TREATMENT WORKS
Environ Health Perspect 117:797–802 (2009). doi:10.1289/ehp.0800197
MAN WITH BOOBS
• ESTEROIDES-TESTOSTERONA EM EXCESSO CONVERTIDA EM ESTROGÉNIO
• EXCESSO DE PROTEÍNA CONVERTIDA EM GORDURA
• PATOLÓGICA (GINECOMASTIA)
• BEBER ÁGUA?
EFFECTS OF CORTISOL AND GROWTH HORMONE ON LIPOLYSIS
The Journal of Clinical Endocrinology & Metabolism 85: 799–803, 2000
GH
• SLEPP
• ACID LACTIC
• RT, HIT, HIIT, HIRT
CORTISOL
• Insulin
• LPL
• CALÇADÃO
LIP
OLY
SIS
LIPO
LYSIS
“Furthermore, the present results suggest that the lipolytic effect of GH is strengthened in the presence of cortisol.”
• Insulina + LPL• IN --> HC
• FFM & FM• Fatty Acids
• Glucagon + HSL• OUT --> FATTY ACIDS
The Journal of Clinical Endocrinology & Metabolism 85: 799–803, 2000